Zhe (Jerry) Zhou
About Zhe (Jerry) Zhou
Zhe (Jerry) Zhou Partner at Laurion Capital Management
Zhe (Jerry) Zhou is a partner at Laurion Capital Management, a role he assumed in 2017. His responsibilities include developing both fundamental and technical quantitative strategies, as well as quant-informed discretionary strategies. He has significantly contributed to enhancing the firm's biotech investment strategies. His prior experience includes serving as the Co-Head of LCM Shanghai Investment Consulting Co, Ltd, where he led the quantitative equity research team.
Zhe (Jerry) Zhou Education Background
Zhe (Jerry) Zhou has an extensive academic background in the sciences. He received a B.S. in Biological Sciences from Tsinghua University in 2004. Following this, he pursued doctoral studies in Biochemistry and Molecular Pharmacology at Harvard University, completing his Ph.D. in 2008 under the guidance of Prof. Christopher T. Walsh. His academic journey led him to contribute to significant research efforts, including experimentally determining and publishing the world’s first crystal structure of the SARS-COV main protease in 2003.
Zhe (Jerry) Zhou Quantitative Research Experience
With nearly two decades of experience in quantitative research, Zhe (Jerry) Zhou's expertise spans a range of specialties within this field. He has been instrumental in developing various quantitative strategies at Laurion Capital Management. His background also includes leading a Shanghai-based quantitative equity research team, focusing on innovative approaches in the sector. His role involves crafting strategies with a deep understanding of both fundamental and technical aspects.
Zhe (Jerry) Zhou Contributions to Scientific Research
Throughout his academic career, Zhe (Jerry) Zhou has made notable contributions to scientific research. One of his key achievements was being part of the research team that published the world’s first crystal structure of the SARS-COV main protease in 2003. Additionally, he has authored nine research articles that have been published in international journals, reinforcing his reputation in the scientific community. His work has combined rigorous experimental approaches with detailed biochemical and molecular pharmacological insights.